Why is naloxone prescription not more common in emergency departments? A survey of physician practices and attitudes

Author:

Nykin David,Belisle Haley CampbellORCID,Saadat Soheil,Luu Tiffany,Sahota Preet Kaur,Chakravarthy Bharath

Abstract

Objective: Emergency physicians (EPs) have a singular opportunity to prescribe naloxone and decrease fatal overdoses in opioid users. We surveyed EPs patterns of naloxone prescription and identified barriers to prescribing naloxone. Design: Surveys were conducted at an emergency medicine conference from 2018 to 2019. We used a Likert scale for all questions and a chi-square or chi-square for trend tests to determine statistical significance. Setting: Emergency medicine conferences and emergency departments. Participants: Forty-one EPs were surveyed. Intervention: Oral survey. Main outcome measures: Prevalence of naloxone prescription and EP attitude toward naloxone. Results: 65.0 percent of residents and 33.3 percent of attending physicians had never prescribed naloxone to patients. 90.2 percent believed ED naloxone prescription is safe, 82.9 percent did not refrain from prescribing due to ethical concerns, and 73.2 percent believed it is not a waste of resources. Conclusions: Many resident physicians had never prescribed naloxone despite agreeing it was safe, ethical, and a productive use of resources. The time needed to counsel patients on naloxone use was a barrier to prescription, and various interventions are needed to make this practice more common.

Publisher

Weston Medical Publishing

Subject

Anesthesiology and Pain Medicine,Pharmacology (medical),General Medicine

Reference18 articles.

1. Vital Signs: Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia. 2019-2020. Available at https://www.cdc.gov/mmwr/volumes/71/wr/mm7129e2.htm?s_cid=mm7129e2_w. Accessed July 22, 2022.

2. National Institute on Drug Abuse: Opioid overdose crisis. 2021. Available at https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis. Accessed May 26, 2021.

3. Smart R, Pardo B, Davis CS: Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction. 2021; 116(1): 6-17. DOI: 10.1111/add.15163.

4. Rees DI, Sabia JJ, Argys LM, et al.: With a little help from my friends: The effects of good Samaritan and naloxone access laws on opioid-related deaths. J Law Econ. 2019; 62(1): 1-27.

5. Food and Drug Administration: FDA approves first over-the-counter naloxone nasal spray. US Food and Drug Administration. 2023. Available at https://www.fda.gov/newsevents/press-announcements/fda-approves-first-over-counternaloxone-nasal-spray. Accessed June 2, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3